Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China · Delayed Price · Currency is CNY 9.27
-0.19 (-2.01%)
Sep 10, 2026, 3:04 PM CST
SHE:000590 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -48.23 | -50.52 | -125.47 | 25.25 | 18.11 | 35.44 |
Depreciation & Amortization | 31.13 | 31.54 | 29.21 | 28.04 | 24.36 | 19.48 |
Other Amortization | 2.89 | 2.26 | 0.89 | 1.1 | 0.97 | 1.2 |
Loss (Gain) From Sale of Assets | 0.71 | -2.42 | -0 | -13.33 | -0.02 | -0.51 |
Asset Writedown & Restructuring Costs | 25.79 | 24.92 | 118.71 | 5.59 | 0.67 | 2.02 |
Loss (Gain) From Sale of Investments | -1.5 | -0.78 | 0.5 | -2.79 | -2.77 | -3.33 |
Provision & Write-off of Bad Debts | -0.18 | -0.18 | 0.25 | - | - | - |
Other Operating Activities | 10.91 | 11.9 | 29.35 | 4.99 | 2.07 | -1.86 |
Change in Accounts Receivable | -14.77 | 38.52 | -4.29 | -45.83 | 2.92 | -26.83 |
Change in Inventory | 2.49 | 14.46 | 5.13 | -11.64 | -7.33 | -35.57 |
Change in Accounts Payable | -36.63 | -34.32 | -32.03 | -28.32 | 15.52 | 35.66 |
Change in Other Net Operating Assets | 6.3 | -0.38 | - | 7.96 | -0.98 | -0.1 |
Operating Cash Flow | -24.19 | 28.96 | 17.39 | -29.39 | 54.47 | 25.2 |
Operating Cash Flow Growth | - | 66.54% | - | - | 116.20% | -51.06% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -42.06 | -48.81 | -32.1 | -22.04 | -18.68 | -25.88 |
Sale of Property, Plant & Equipment | 2.45 | 0.13 | 0.01 | 0.2 | 2.67 | 0.71 |
Cash Acquisitions | - | - | - | - | -214.52 | - |
Investment in Securities | -35 | - | - | 25 | 50 | -94 |
Other Investing Activities | 60.13 | 60.3 | 0.54 | 0.99 | 2.99 | 3.18 |
Investing Cash Flow | -14.49 | 11.62 | -31.55 | 4.15 | -177.54 | -115.98 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 6 | - | - | - | - |
Long-Term Debt Issued | - | 48.68 | 38.11 | 20 | 130.8 | 0.05 |
Total Debt Issued | 20.19 | 54.68 | 38.11 | 20 | 130.8 | 0.05 |
Short-Term Debt Repaid | - | -6 | - | - | - | - |
Long-Term Debt Repaid | - | -75.09 | -38.22 | -48.13 | -20.94 | -7.79 |
Lease Payments | -3.19 | -3.19 | -3.33 | -3.13 | -2.94 | -2.74 |
Total Debt Repaid | -86.09 | -81.09 | -38.22 | -48.13 | -20.94 | -7.79 |
Net Debt Issued (Repaid) | -65.91 | -26.41 | -0.11 | -28.13 | 109.86 | -7.74 |
Issuance of Common Stock | - | - | 0.03 | - | - | - |
Common Dividends Paid | -2.52 | -3.35 | -3.47 | -4.2 | -0.34 | -0.06 |
Other Financing Activities | -6.5 | -1.4 | 0.23 | 0.82 | 2 | 2 |
Financing Cash Flow | -74.93 | -31.17 | -3.31 | -31.51 | 111.52 | -5.81 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Cash Flow | -113.61 | 9.41 | -17.47 | -56.75 | -11.55 | -96.59 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -66.25 | -19.85 | -14.71 | -51.43 | 35.79 | -0.68 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -20.11% | -5.88% | -4.29% | -12.71% | 10.21% | -0.23% |
Free Cash Flow Per Share | -0.28 | -0.08 | -0.06 | -0.21 | 0.15 | -0.00 |
Levered Free Cash Flow | 22.04 | 47.02 | -8.13 | -64.34 | 21.79 | -23.75 |
Unlevered Free Cash Flow | 24.15 | 49.13 | -5.84 | -61.55 | 22.52 | -23.45 |
Free Cash Flow After Leases | -69.44 | -23.04 | -18.04 | -54.57 | 32.85 | -3.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 32.21 | 46.31 | 36.36 | 52.07 | 32.68 | 32.78 |
Change in Working Capital | -45.71 | 12.23 | -36.05 | -78.24 | 11.08 | -27.24 |